Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut microbiome

ABSTRACT: Murine intestinal microbiome to explore the role of gp130 signalling Targeted loci

PROVIDER: PRJNA705611 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13817000_1.fastq.gz	Fastqsanger.gz
	SRR13817000_2.fastq.gz	Fastqsanger.gz
	SRR13817001_1.fastq.gz	Fastqsanger.gz
	SRR13817001_2.fastq.gz	Fastqsanger.gz
	SRR13817003_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 76

Similar Datasets

human and murine gut microbiome

Project description:human and murine gut microbiome Targeted loci

| PRJNA635258 | ENA

human and murine gut microbiome

Project description:human and murine gut microbiome Targeted loci

| PRJNA635260 | ENA

gut metagenome

Project description:Murine and Humanized intestinal microbiome in alcoholic liver disease Targeted loci

| PRJNA525701 | ENA

Human gut microbiome

Project description:Human gut microbiome 16s Targeted loci

| PRJNA436992 | ENA

Rodent gut microbiome

Project description:Rodent gut microbiome Targeted loci environmental

| PRJNA810848 | ENA

mice gut microbiome

Project description:mice gut microbiome Targeted loci environmental

| PRJNA784088 | ENA

pig gut metagenome

Project description:pig intestinal content Targeted loci

| PRJNA383292 | ENA

Therapeutic interference with mTorc1 restricts inflammation-associated and Stat3-dependent gastro-intestinal tumourigenesis in mice

Project description:Gp130 receptor engagement on neoplastic cells provides a link by which an inflammatory microenvironment facilitates tumour promotion. Although hyperactivation of the gp130-dependent Stat3 signalling node is commonly observed in solid tumours, Stat3 remains a challenging therapeutic target. To mimic excessive Stat3 signalling, we molecularly validate the gp130FF mouse as a preclinical model for inflammation-associated intestinal-type gastric cancer (IGC), with aberrant mammalian target of rapamycin (mTOR) pathway activity as shared feature. Accordingly, administration of the mTorc1 inhibitor RAD001 reversibly reduced IGC burden in gp130FF mice and suppressed colitis-associated cancer in wild-type mice. Since the therapeutic effect of RAD001 occurs independently of Stat3 hyperactivation, which is also dispensable for gp130-dependent engagement of the PI3K/Akt/mTorc1 pathway, we conclude that mTorc1 signalling limits tumour promoting Stat3 activity The mouse whole-genome gene expression profiling was performed on Illumina's MouseWG-6 v2.0 Expression BeadChips for 24 mice, with 8 mice in each group (gp130WT antral tissue, gp130FF unaffected antral tissue and gp130FF tumour tissue).

2013-01-29 | E-GEOD-35808 | biostudies-arrayexpress

gut metagenome

Project description:Intestinal contents of piglets Targeted loci

| PRJNA379029 | ENA

Therapeutic interference with mTorc1 restricts inflammation-associated and Stat3-dependent gastro-intestinal tumourigenesis in mice

2013-01-29 | GSE35808 | GEO